Levocetirizine and montelukast in the treatment of inflammation mediated conditions
AssigneeIRR, Inc.
InventorBruce Chandler May
Life of this patent
Estimating the term…
Abstract
The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
Claims11
A method of treating an inflammatory NFκB-mediated neurological condition, the method comprising administering to a patient an effective amount of a combination of levocetirizine and montelukast.
Dependencies are inferred from the claim text.